News
Using a hybrid, closed-loop insulin delivery system in the auto mode shows improved glycemic control and a favorable safety ...
Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...
Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...
LifeSouth Community Blood Centers is offering free A1c testing to blood donors until Sunday, August 31, providing an ...
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns
Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with ...
After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...
Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials ...
ANSWER: Your A1C was in the diabetes range when it was 6.7%, and even though it is now in the range of prediabetes, once you have diagnosed diabetes, this remains your diagnosis even if your blood ...
My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my weight by about 20 pounds and my A1C level by about 0.5%. I also take diltiazem for hypertension, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results